Skip to main content

Published locations for HER2-negative metastatic BC: First-line nivolumab, bevacizumab, paclitaxel shows promise in phase 2

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HER2-negative metastatic BC: First-line nivolumab, bevacizumab, paclitaxel shows promise in phase 2

User login

  • Reset your password
  • /content/her2-negative-metastatic-bc-first-line-nivolumab-bevacizumab-paclitaxel-shows-promise-phase
  • /hematology-oncology/article/256510/breast-cancer/her2-negative-metastatic-bc-first-line-nivolumab
  • /breast-cancer-icymi/article/256510/breast-cancer/her2-negative-metastatic-bc-first-line-nivolumab